BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17172502)

  • 1. Fishing for vascular invasion.
    Batistatou A; Charalabopoulos K
    Int J Surg Pathol; 2007 Jan; 15(1):68. PubMed ID: 17172502
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
    Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of vascular invasion in breast cancer].
    Fujimori M; Izuo M; Takano A; Usui T; Kawai T
    Gan No Rinsho; 1968 May; 14(5):389-93. PubMed ID: 5693797
    [No Abstract]   [Full Text] [Related]  

  • 4. The reaction of blood vessels to tumour invasion.
    Iyengar B; Chandra K
    Indian J Cancer; 1976 Mar; 13(1):9-14. PubMed ID: 965024
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer. A hypothesis.
    Cocker R; Oktay MH; Sunkara JL; Koss LG
    Med Hypotheses; 2007; 69(1):57-63. PubMed ID: 17257776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2008; 49(2):181-8. PubMed ID: 18516324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
    Gao D; Du J; Cong L; Liu Q
    Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive micropapillary carcinoma of the breast: Cytomorphology of a metastatic deposit.
    Lokuhetty MD; Fernandopulle N
    Diagn Cytopathol; 2007 Jan; 35(1):65-6. PubMed ID: 17173295
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.
    Yamaguchi J; Ohtani H; Nakamura K; Shimokawa I; Kanematsu T
    Am J Clin Pathol; 2008 Sep; 130(3):382-8. PubMed ID: 18701411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
    Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
    Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
    Vincent-Salomon A; Caly M; De Rycke Y; Fréneaux P; Klijanienko J; Laé M; Viard F; Nos C; Bidard FC; Alran S; Salmon R; Kirova Y; Pierga JY; Sigal-Zafrani B; Sastre-Garau X
    Eur J Cancer; 2009 Jul; 45(11):1979-86. PubMed ID: 19375305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
    Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
    Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous rectal metastasis from invasive lobular carcinoma of the breast.
    Yanagisawa K; Yamamoto M; Ueno E; Ohkouchi N
    J Gastroenterol Hepatol; 2007 Apr; 22(4):601-2. PubMed ID: 17376062
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast (Br J Surg 2008; 95: 547-554).
    Meijnen P; Rutgers EJ
    Br J Surg; 2008 Oct; 95(10):1305; author reply 1305. PubMed ID: 18763257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.